MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $272,604 | -42.9% | 7,332 | +3.3% | 0.15% | -32.6% |
Q2 2022 | $477,000 | +118.8% | 7,101 | +377.2% | 0.22% | +98.2% |
Q4 2021 | $218,000 | -25.3% | 1,488 | -41.8% | 0.11% | -43.6% |
Q2 2020 | $292,000 | +4071.4% | 2,558 | +2621.3% | 0.20% | +9650.0% |
Q3 2019 | $7,000 | -88.1% | 94 | -83.7% | 0.00% | -90.9% |
Q2 2019 | $59,000 | – | 577 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |